Efnisyfirlit

• Cover
• Front Matter
• 1. Molecular Biotechnology: From DNA Sequence to Therapeutic Protein
• 2. Biophysical and Biochemical Characteristics of Therapeutic Proteins
• 3. Protein Stability and Characterization
• 4. Production and Purification of Recombinant Proteins
• 5. Formulation of Biologics Including Biopharmaceutical Considerations
• 6. Pharmacokinetics and Pharmacodynamics of Therapeutic Peptides and Proteins
• 7. Immunogenicity of Therapeutic Proteins
• 8. Monoclonal Antibodies: From Structure to Therapeutic Application
• 9. Genomics, Other “OMIC” Technologies, Precision Medicine, and Additional Biotechnology-Related Techniques
• 10. Dispensing Biotechnology Products: Handling, Professional Education, and Product Information
• 11. Economic Considerations in Medical Biotechnology
• 12. Regulatory Framework for Biosimilars
• 13. An Evidence-Based Practice Approach to Evaluating Biotechnologically Derived Medications
• 14. Vaccines
• 15. Oligonucleotides
• 16. Gene Therapy
• 17. Advanced Therapies: Clinical, Non-clinical and Quality Considerations
• 18. Insulin
• 19. Follicle-Stimulating Hormone
• 20. Human Growth Hormone
• 21. Recombinant Coagulation Factors and Thrombolytic Agents
• 22. Recombinant Human Deoxyribonuclease I
• 23. Monoclonal Antibodies in Cancer
• 24. Hematopoietic Growth Factors
• 25. Monoclonal Antibodies in Solid Organ Transplantation
• 26. Antibody-Based Biotherapeutics in Inflammatory Diseases
• 27. Interferons and Interleukins
• Back Matter